Sign in

CIK 0001847367

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

ALUMIS INC.

Sign in to watch
Ticker
ALMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-231-6625
Business address
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
FL2021-001, Inc.
Open-market buys, last 90 days
$10,726,255
in 1 filing
Open-market sales, last 90 days
$1,037,650
in 7 filings

Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-30 Srivastava Sapna Director Grant or award +3,553 3,553
2026-06-30 Srivastava Sapna Director Grant or award · Stock Option (Right to Buy) +15,528 15,528
2025-07-30 Srivastava Sapna Director Grant or award · Stock Option (Right to Buy) +49,800 49,800
2024-07-01 Srivastava Sapna Director Returned to the company · Stock Option (Right to Buy) −28,877 0
2024-07-01 Srivastava Sapna Director Grant or award · Stock Option (Right to Buy) +28,877 28,877
2024-07-01 Srivastava Sapna Director Returned to the company · Stock Option (Right to Buy) −29,946 0
2024-07-01 Srivastava Sapna Director Grant or award · Stock Option (Right to Buy) +29,946 29,946
2024-06-27 Srivastava Sapna Director Grant or award · Stock Option (Right to Buy) +28,877 28,877

Page 1 of 1 · 8 trades